Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma
Open Access
- 1 August 2023
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (15) , 13727-13739
Abstract
Purpose: Cervical adenocarcinoma is one of the most common types of cervical cancer and its incidence is increasing. The biological behavior and treatment outcomes of cervical adenocarcinoma (CA) differ from those of squamous cell carcinoma (SCC). We sought to develop a model to predict recurrence and cancer-specific survival (CSS) deaths in CA patients. Methods: 131 patients were included in model development and internal validation, and patients from the SEER database (N = 1679) were used for external validation. Multivariable Cox proportional hazards regression analysis was used to select predictors of relapse-free survival (RFS) and CSS and to construct the model, which was presented as two nomograms. Internal validation of the nomograms was performed using the bootstrap resampling method. Results: Age, FIGO (International Federation of Gynecology and Obstetrics) stage, size of the tumor, lymph metastasis and depth of invasion were identified as independent prognostic factors for RFS, while age, FIGO stage, size of the tumor and number of positive LNs were identified as independent prognostic factors for CSS. The nomogram of the recurrence model predicted 2- and 5-year RFS, with optimism adjusted c-statistic of 75.41% and 74.49%. Another nomogram predicted the 2- and 5-year CSS with an optimism-adjusted c-statistic of 83.22% and 83.31% after internal validation; and 68.6% and 71.33% after external validation. Conclusions: We developed and validated two effective nomograms based on static nomograms or online calculators that can help clinicians quantify the risk of relapse and death for patients with early-stage CA.Keywords
This publication has 24 references indexed in Scilit:
- A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissectionGynecologic Oncology, 2017
- Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete ResectionAsian Pacific Journal of Cancer Prevention, 2015
- Prognostic factors affecting cervical adenocarcinoma: 10 years experience in a single institutionArchives of Gynecology and Obstetrics, 2015
- Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in Gynecologic Oncology Group trials of cisplatin-based chemoradiationGynecologic Oncology, 2014
- [Introduction of WHO classification of tumours of female reproductive organs, fourth edition].2014
- Individualized Prediction of Overall Survival After Postoperative Radiation Therapy in Patients With Early-Stage Cervical Cancer: A Korean Radiation Oncology Group Study (KROG 13-03)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapyGynecologic Oncology, 2013
- Nomogram prediction for overall survival of patients diagnosed with cervical cancerBritish Journal of Cancer, 2012
- A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB–IIAGynecologic Oncology, 2011
- Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervixBritish Journal of Cancer, 2010